Only half of people with early-onset cancers reported discussing fertility preservation options prior to their oncology treatments, according to results of a cross-sectional study published in JAMA Network Open.
The Neuroendocrine Tumor Research Foundation has joined the Cancer History Project to preserve the history of research, care, and survivorship of this uncommon disease.
